Status:
COMPLETED
Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Whey Protein
Postoperative Outcomes
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Major surgeries including gynecological cancer surgery can make surgical stress that leads to increased burden of postoperative complications, delayed length of hospital stay and increased mortality r...
Detailed Description
During admission, Participants will be randomized by a computer program into two groups as the whey protein supplement group and control group. Both groups will undergo nutritional assessment on the f...
Eligibility Criteria
Inclusion
- A Woman who suspected or diagnosed with ovarian and endometrial Cancer
- A Woman who candidates for elective Surgical staging of Laparotomy operation in Rajavithi hospital
- Aged 18-70 years old
- Can communicate and understand Thai language very well
- A woman voluntarily participated in the research
Exclusion
- Allergy to whey protein and protein product such as cow milk and egg
- A Woman who diagnosed with Hypertension, Diabetes Mellitus, Chronic Kidney Disease, Heart disease and Chronic liver disease
- A Woman who expected difficult operation such as severe pelvic adhesion or required other surgeon for co-evaluation
- Pregnant woman or breastfeeding
- A Woman who denied surgery
- A Woman who currently take a protein supplement
- A Woman who take Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) , Bisphosphonates, Levodopa ,Tetracycline and Quinolone
Key Trial Info
Start Date :
August 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06035510
Start Date
August 21 2023
End Date
October 31 2024
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi
Phaya Thai, ratchathewi, Thailand, 10400